Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Jun;141(6):492-509.
doi: 10.1111/acps.13170. Epub 2020 Apr 6.

Blood biomarker levels of methylation capacity in autism spectrum disorder: a systematic review and meta-analysis

Bao-Qiang Guo  1 , Shi-Bin Ding  2 , Hong-Bin Li  1
Affiliations
Meta-Analysis

Blood biomarker levels of methylation capacity in autism spectrum disorder: a systematic review and meta-analysis

Bao-Qiang Guo et al. Acta Psychiatr Scand. 2020 Jun.

Abstract

Objective: To compare the peripheral blood levels of methionine (Met), S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH), and the SAM/SAH ratio (the most core and predictive indices of cellular methylation ability) between patients with autism spectrum disorder (ASD) and control subjects.

Methods: PubMed, Embase, PsycINFO, Web of Science, and Cochrane Library were searched from inception to August 2, 2019, without language restriction. The random-effects model was used to summarize effect sizes.

Results: We retrieved 1,493 records, of which 22 studies met inclusion criteria. Our overall analyses revealed that individuals with ASD had significantly decreased levels of Met (22 studies; Hedges' g = -0.62; 95% confidence interval [CI]: -0.89, -0.35), SAM (8 studies; Hedges' g = -0.60; 95% CI: -0.86, -0.34), and the SAM/SAH ratio (8 studies; Hedges' g = -0.98; 95% CI: -1.30, -0.66) and significantly increased levels of SAH (8 studies; Hedges' g = 0.69; 95% CI: 0.43, 0.94). The findings of the overall analyses were quite stable after being verified by sensitivity analyses and in agreement with the corresponding outcomes of subgroup analyses. Additionally, our results from meta-analytic techniques confirmed that the effect estimates of this meta-analysis did not originate from publication bias.

Conclusion: Individuals with ASD have substantially aberrant peripheral blood levels of Met, SAM, SAH, and the SAM/SAH ratio, which supports the association between impaired methylation capacity and ASD. Therefore, further investigations into these indices as potential biomarkers for diagnosis and therapeutic targets of ASD are warranted.

Keywords: autism spectrum disorder; blood biomarkers; meta-analysis; methylation capacity.

PubMed Disclaimer

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA: American Psychiatric Association; 2013.
    1. Ferri SL, Abel T, Brodkin ES. Sex differences in autism spectrum disorder: a Review. Curr Psychiatry Rep 2018;20:9.
    1. Baio J, Wiggins L, Christensen DL et al. Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2014. MMWR Surveillance Summaries 2018;67:1-23.
    1. Michalak EM, Burr ML, Bannister AJ, Dawson MA. The roles of DNA, RNA and histone methylation in ageing and cancer. Nat Rev Mol Cell Biol 2019;20:573-589.
    1. Yao B, Christian KM, He C, Jin P, Ming G-L, Song H. Epigenetic mechanisms in neurogenesis. Nat Rev Neurosci 2016;17:537-549.

Publication types